Jun 12

MDMA clinical trials report profound long-term impact on PTSD suffers

Posted in: Today's Chili

Non-profit organization MAPS has published the long-term results of multiple Phase 2 clinical trials on the use of MDMA and therapy to treat PTSD. The results were favorable, finding that most participants experienced extended benefits from the treatment for the duration of at least one year. More than half of the volunteers no longer met the diagnostic criteria for PTSD … Continue reading

No Responses to “MDMA clinical trials report profound long-term impact on PTSD suffers”

Post a Comment